Big Data lowers prescription errors, IoT enables transparency in medical insurance claims: Raghav Kini

Bengaluru, September 24, 2022:

 

Indian healthcare sees digital transformation as an indispensable development in the industry. This is driven by the patient-centric approach to healthcare where accurate diagnosis and treatment are the need of the hour.
 
The assessment of user and prescribed medication data sees Big Data can decrease errors related to prescription. IoT (Internet of Things) devices bring transparency to the underwriting, claims administration, risk evaluation, and pricing processes between customers and insurers, help insurers to spot false claims and identify potential underwriters and assist them in significantly lowering claims, said Raghav Kini, sales lead, Healthminds Consulting.
 
With digital transformation healthcare providers function efficiently, better comprehend patient needs, foster trust, and give a better user experience. Thus technology is impacting all facets of healthcare by making it easier to access treatment, enhancing quality of care, and lower costs, he added.
 
Quoting that the global digital health market in 2021 was US$ 175.6 billion and expected to expand at a CAGR of 27.7% between 2022 to 2030, Kini said that this is because of rising smartphone adoption, better internet connectivity, improved healthcare IT infrastructure, growing healthcare costs, rising prevalence of chronic diseases, leading to accessibility of remote and virtual care. The incorporation of digitization is being perceived as a key component of a comprehensive approach to spur growth for new prospects in the healthcare sector, he said.
 
Time savings, constant access to patient's medical records, real-time coordination, and seamless communication are the main factors, which are propelling digital healthcare. Some key  reasons that are making this transformation indispensable are Healthcare Accessibility, Improving Life Expectancy, Enhancing Resource Management in Hospitals, Planning using tactical insights, to name a few.
 
The interactions between patients and healthcare providers have transformed with telemedicine solutions. Remote monitoring is done with wearables and IoT-based health sensors notify patients and the medical practitioner.
 
Data-driven insights in healthcare can generate life-saving outcomes. By forecasting patient admission rates, patterns derived from data analysis, can help to improve staffing in medical facilities. The real-time position of medical equipment can also be tracked, using IoT devices having sensors integrated into them, which helps check the equipment availability.  Also, IoT-based hygiene monitoring tools like intelligent cameras can aid hygiene management in hospitals, said Kini.
 
A close assessment of the outcomes of patient examinations across demography and geography can help to draft an appropriate health strategy, particularly during outbreaks and pandemic-like situations, Kini told Pharmabiz in an email.
 
Using Virtual Reality (VR), immersive experiences can be undertaken in healthcare. As a potent diagnostic tool VR can enable doctors and medical professionals to make precise diagnoses. This is currently used in conjunction with MRI/CT scans, and because no intrusive procedures are required. VR is also being used for pain reduction and physical therapies.
 
Artificial intelligence (AI) is implemented to reduce cost and time. Healthcare systems can automatically forecast, understand, and respond. From detecting connections between genetic codes to operating robots that help in surgery, monitoring chronic conditions, and doing risk assessments, AI has unleashed benefits in healthcare including aid in the successful testing and creation of vaccines and medicine. It can automate routine actions, freeing up administrators to focus on more complex ones.
 
Further, interactive technologies remind patients about their medicine, checkups and also keep them from feeling lonely. Similarly, robots and advanced technology are available for microsurgeries and psychological relief, said Kini. Pharmabiz